Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_assertion type Assertion NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_head.
- NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_assertion description "[In oligodendroglioma (OG) and oligoastrocytoma (OA), presence of 1p/19q codeletions is highly predictive of response to treatment and is often associated with the methylated MGMT promoter; hence, this study queries whether the presence of 1p/19q codeletions in OG/OA correlates with a higher rate of PsP following therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_provenance.
- NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_assertion evidence source_evidence_literature NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_provenance.
- NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_assertion SIO_000772 24285548 NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_provenance.
- NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_assertion wasDerivedFrom befree-2016 NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_provenance.
- NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_assertion wasGeneratedBy ECO_0000203 NP1132200.RA2Nv1_pyPAx0W6aLl7CKPIGHxXxvZd3ziScolE-vlEko130_provenance.